Common Shares Outstanding: The number of class A shares currently held by investors.
ProQR Therapeutics N.V. (PRQR) had Common Shares Outstanding of 107.71M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$3.37M |
|
$-12.86M |
|
-- |
|
$3.37M |
|
$16.56M |
|
$-13.19M |
|
$0.33M |
|
$-12.86M |
|
$-12.86M |
|
$-12.86M |
|
$-12.86M |
|
$-12.86M |
|
$-12.86M |
|
$-13.19M |
|
$-12.36M |
|
105.34M |
|
105.34M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$130.13M |
|
$15.22M |
|
$15.22M |
|
$145.35M |
|
$38.73M |
|
-- |
|
$39.91M |
|
$78.64M |
|
$66.71M |
|
$66.71M |
|
$66.71M |
|
|
Common Shares Outstanding |
107.71M |
| Cash Flow Statement Financials | |
$-46.09M |
|
$-0.58M |
|
$-1.45M |
|
$174.64M |
|
$124.94M |
|
$-49.71M |
|
$3.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.36 |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
100.00% |
|
-391.53% |
|
-391.53% |
|
-- |
|
-381.89% |
|
-381.89% |
|
$-46.67M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-19.28% |
|
-19.28% |
|
-8.85% |
|
-19.28% |
|
$0.62 |
|
$-0.44 |
|
$-0.44 |
|